Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 84 | 2024 | 4242 | 7.560 |
Why?
|
Graft Rejection | 73 | 2024 | 4481 | 4.870 |
Why?
|
BK Virus | 8 | 2024 | 120 | 3.080 |
Why?
|
Graft Survival | 40 | 2024 | 3843 | 2.770 |
Why?
|
Polyomavirus Infections | 7 | 2024 | 192 | 2.250 |
Why?
|
Immunosuppressive Agents | 35 | 2022 | 4190 | 1.850 |
Why?
|
Heart Transplantation | 35 | 2020 | 3258 | 1.710 |
Why?
|
Organ Transplantation | 12 | 2024 | 1165 | 1.670 |
Why?
|
Viremia | 6 | 2024 | 707 | 1.580 |
Why?
|
T-Lymphocytes, Regulatory | 12 | 2022 | 3092 | 1.460 |
Why?
|
Transplantation | 4 | 2019 | 221 | 1.440 |
Why?
|
Facial Transplantation | 7 | 2021 | 222 | 1.370 |
Why?
|
Kidney Failure, Chronic | 13 | 2024 | 2478 | 1.350 |
Why?
|
HLA Antigens | 11 | 2021 | 1331 | 1.300 |
Why?
|
Tumor Virus Infections | 5 | 2024 | 435 | 1.250 |
Why?
|
Immunoconjugates | 29 | 2013 | 963 | 1.180 |
Why?
|
Isoantibodies | 9 | 2024 | 675 | 1.150 |
Why?
|
Immune Tolerance | 17 | 2020 | 2307 | 0.920 |
Why?
|
Histocompatibility Testing | 7 | 2021 | 716 | 0.790 |
Why?
|
Plasmapheresis | 4 | 2024 | 207 | 0.790 |
Why?
|
Apolipoproteins | 2 | 2016 | 327 | 0.770 |
Why?
|
Antigens, Differentiation | 26 | 2007 | 918 | 0.760 |
Why?
|
Lipoproteins, HDL | 3 | 2016 | 675 | 0.760 |
Why?
|
Magnesium Deficiency | 1 | 2020 | 48 | 0.710 |
Why?
|
Dendritic Cells | 5 | 2019 | 2726 | 0.710 |
Why?
|
Histocompatibility | 3 | 2018 | 319 | 0.700 |
Why?
|
Reperfusion Injury | 5 | 2020 | 1026 | 0.700 |
Why?
|
Antiviral Agents | 7 | 2018 | 3048 | 0.680 |
Why?
|
T-Lymphocytes | 32 | 2024 | 10203 | 0.660 |
Why?
|
Kidney | 15 | 2024 | 7033 | 0.660 |
Why?
|
Tissue Donors | 13 | 2021 | 2335 | 0.640 |
Why?
|
HMGB1 Protein | 2 | 2020 | 136 | 0.640 |
Why?
|
Transplantation, Homologous | 24 | 2023 | 4822 | 0.630 |
Why?
|
Magnesium | 2 | 2022 | 804 | 0.600 |
Why?
|
Th2 Cells | 9 | 2018 | 1071 | 0.580 |
Why?
|
Transplants | 1 | 2019 | 206 | 0.560 |
Why?
|
Rats, Inbred Lew | 29 | 2010 | 1159 | 0.560 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2022 | 668 | 0.540 |
Why?
|
Hemodiafiltration | 1 | 2016 | 18 | 0.540 |
Why?
|
Leukocytes, Mononuclear | 3 | 2022 | 1838 | 0.520 |
Why?
|
Living Donors | 4 | 2018 | 643 | 0.510 |
Why?
|
Anti-Infective Agents | 2 | 2014 | 983 | 0.500 |
Why?
|
Crime | 1 | 2016 | 204 | 0.490 |
Why?
|
Immune System | 2 | 2019 | 792 | 0.460 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1468 | 0.460 |
Why?
|
Hypoparathyroidism | 1 | 2015 | 136 | 0.450 |
Why?
|
Renal Replacement Therapy | 1 | 2016 | 281 | 0.450 |
Why?
|
Interleukin-6 | 5 | 2017 | 3210 | 0.440 |
Why?
|
Parathyroidectomy | 1 | 2015 | 242 | 0.430 |
Why?
|
Teriparatide | 1 | 2015 | 226 | 0.430 |
Why?
|
Tissue and Organ Harvesting | 1 | 2016 | 373 | 0.430 |
Why?
|
Postoperative Complications | 11 | 2024 | 15637 | 0.410 |
Why?
|
Atovaquone | 1 | 2012 | 56 | 0.400 |
Why?
|
Antigens, CD | 31 | 2011 | 4009 | 0.400 |
Why?
|
Tissue and Organ Procurement | 2 | 2019 | 963 | 0.390 |
Why?
|
Lectins, C-Type | 1 | 2015 | 585 | 0.390 |
Why?
|
Humans | 129 | 2024 | 761222 | 0.390 |
Why?
|
Pneumocystis carinii | 1 | 2012 | 72 | 0.380 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2014 | 1351 | 0.380 |
Why?
|
Lymphocyte Activation | 15 | 2021 | 5478 | 0.380 |
Why?
|
Complement System Proteins | 1 | 2014 | 737 | 0.370 |
Why?
|
Isoantigens | 8 | 2022 | 559 | 0.360 |
Why?
|
Diarrhea | 1 | 2017 | 1316 | 0.360 |
Why?
|
Fluoroquinolones | 2 | 2010 | 307 | 0.360 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2012 | 242 | 0.350 |
Why?
|
Virus Activation | 2 | 2017 | 319 | 0.350 |
Why?
|
Hypophosphatemia | 1 | 2011 | 92 | 0.350 |
Why?
|
Transplantation Tolerance | 5 | 2022 | 620 | 0.350 |
Why?
|
Thymus Gland | 5 | 2012 | 1243 | 0.350 |
Why?
|
Biopsy | 10 | 2019 | 6781 | 0.340 |
Why?
|
Kidney Diseases | 6 | 2020 | 2092 | 0.320 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1603 | 0.320 |
Why?
|
Desensitization, Immunologic | 1 | 2014 | 557 | 0.310 |
Why?
|
Biological Products | 1 | 2018 | 915 | 0.310 |
Why?
|
Anemia | 3 | 2008 | 1504 | 0.310 |
Why?
|
Bone Marrow Diseases | 1 | 2010 | 233 | 0.300 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 793 | 0.300 |
Why?
|
Models, Immunological | 4 | 2018 | 515 | 0.290 |
Why?
|
Antibodies, Monoclonal | 15 | 2013 | 9187 | 0.290 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2011 | 1141 | 0.280 |
Why?
|
Phosphates | 1 | 2011 | 763 | 0.280 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2012 | 501 | 0.280 |
Why?
|
Middle Aged | 52 | 2024 | 220858 | 0.280 |
Why?
|
Animals | 78 | 2024 | 168089 | 0.280 |
Why?
|
Lung Transplantation | 4 | 2021 | 1307 | 0.280 |
Why?
|
Clone Cells | 4 | 2009 | 1668 | 0.270 |
Why?
|
Rats | 39 | 2021 | 23705 | 0.270 |
Why?
|
Edema | 1 | 2010 | 764 | 0.260 |
Why?
|
Male | 77 | 2024 | 360703 | 0.260 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6504 | 0.260 |
Why?
|
Th1 Cells | 6 | 2016 | 1042 | 0.260 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2802 | 0.250 |
Why?
|
Hypertension, Malignant | 1 | 2005 | 17 | 0.250 |
Why?
|
Female | 65 | 2024 | 392552 | 0.250 |
Why?
|
Autoantibodies | 3 | 2021 | 2119 | 0.240 |
Why?
|
Renal Insufficiency | 1 | 2011 | 808 | 0.240 |
Why?
|
Rats, Inbred WF | 12 | 2003 | 140 | 0.240 |
Why?
|
Membrane Glycoproteins | 10 | 2011 | 3696 | 0.240 |
Why?
|
Dyslipidemias | 1 | 2012 | 870 | 0.240 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2005 | 153 | 0.230 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2016 | 617 | 0.230 |
Why?
|
Immunologic Factors | 3 | 2019 | 1589 | 0.230 |
Why?
|
Ganciclovir | 1 | 2004 | 253 | 0.230 |
Why?
|
Adult | 42 | 2024 | 221120 | 0.220 |
Why?
|
CD4-Positive T-Lymphocytes | 9 | 2017 | 4373 | 0.220 |
Why?
|
Membrane Proteins | 4 | 2021 | 7851 | 0.220 |
Why?
|
Acute Disease | 11 | 2021 | 7226 | 0.220 |
Why?
|
Antigens, Surface | 1 | 2008 | 1607 | 0.220 |
Why?
|
Glomerulonephritis | 3 | 2014 | 333 | 0.220 |
Why?
|
Mycophenolic Acid | 2 | 2011 | 350 | 0.220 |
Why?
|
CD40 Ligand | 5 | 2002 | 524 | 0.210 |
Why?
|
Treatment Outcome | 21 | 2024 | 64681 | 0.210 |
Why?
|
Antilymphocyte Serum | 3 | 2011 | 491 | 0.200 |
Why?
|
Histocompatibility Antigens Class II | 7 | 2008 | 1435 | 0.200 |
Why?
|
Sepsis | 1 | 2016 | 2585 | 0.200 |
Why?
|
Genetic Variation | 1 | 2017 | 6567 | 0.190 |
Why?
|
Nephrosis, Lipoid | 1 | 2021 | 45 | 0.190 |
Why?
|
Cyclosporine | 8 | 2011 | 776 | 0.190 |
Why?
|
Time Factors | 20 | 2020 | 39957 | 0.190 |
Why?
|
Mice, Inbred BALB C | 7 | 2020 | 6200 | 0.190 |
Why?
|
Histocompatibility Antigens | 4 | 2013 | 467 | 0.180 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 876 | 0.180 |
Why?
|
RNA, Messenger | 3 | 2015 | 12747 | 0.180 |
Why?
|
Rats, Inbred F344 | 6 | 2010 | 826 | 0.180 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2023 | 335 | 0.180 |
Why?
|
Creatinine | 4 | 2017 | 1897 | 0.180 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 433 | 0.170 |
Why?
|
Antibodies | 5 | 2021 | 2415 | 0.170 |
Why?
|
Calcium Oxalate | 1 | 2020 | 75 | 0.170 |
Why?
|
Nephrotic Syndrome | 1 | 2023 | 382 | 0.170 |
Why?
|
Glomerular Filtration Rate | 5 | 2024 | 2182 | 0.160 |
Why?
|
Chronic Disease | 12 | 2017 | 9319 | 0.160 |
Why?
|
Hepatitis C, Chronic | 2 | 2018 | 1027 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2019 | 3493 | 0.160 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7407 | 0.160 |
Why?
|
Mortality | 1 | 2010 | 2896 | 0.160 |
Why?
|
Th17 Cells | 2 | 2018 | 794 | 0.160 |
Why?
|
Interferon-gamma | 6 | 2016 | 3155 | 0.160 |
Why?
|
Mice | 30 | 2021 | 81330 | 0.160 |
Why?
|
Preoperative Care | 2 | 2014 | 2241 | 0.150 |
Why?
|
Interleukin-1beta | 3 | 2014 | 1002 | 0.150 |
Why?
|
Retrospective Studies | 19 | 2024 | 80675 | 0.150 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2018 | 86 | 0.150 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 828 | 0.150 |
Why?
|
Vascular Diseases | 2 | 2019 | 1160 | 0.150 |
Why?
|
Adenosine Triphosphate | 2 | 2022 | 1988 | 0.150 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2016 | 2058 | 0.150 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2024 | 659 | 0.150 |
Why?
|
Transplantation Immunology | 4 | 2008 | 537 | 0.140 |
Why?
|
Skin Transplantation | 9 | 2014 | 1091 | 0.140 |
Why?
|
Aged | 25 | 2024 | 169292 | 0.140 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2018 | 87 | 0.140 |
Why?
|
Prospective Studies | 16 | 2024 | 54437 | 0.140 |
Why?
|
Double-Blind Method | 3 | 2024 | 12341 | 0.140 |
Why?
|
Prognosis | 8 | 2024 | 29688 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor C | 2 | 2019 | 127 | 0.140 |
Why?
|
Granzymes | 2 | 2017 | 276 | 0.140 |
Why?
|
Monocytes | 3 | 2017 | 2570 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2254 | 0.140 |
Why?
|
Interleukin-17 | 2 | 2016 | 913 | 0.140 |
Why?
|
Neoplasms | 2 | 2024 | 22142 | 0.140 |
Why?
|
Antibodies, Blocking | 3 | 2013 | 249 | 0.130 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3163 | 0.130 |
Why?
|
Transplantation Conditioning | 3 | 2018 | 1591 | 0.130 |
Why?
|
Mice, Inbred C57BL | 13 | 2020 | 22128 | 0.130 |
Why?
|
Microscopy, Electron | 3 | 2015 | 2561 | 0.130 |
Why?
|
Signal Transduction | 8 | 2024 | 23419 | 0.130 |
Why?
|
Antigen Presentation | 1 | 2021 | 1251 | 0.120 |
Why?
|
Coronary Artery Disease | 4 | 2024 | 6506 | 0.120 |
Why?
|
Inflammation Mediators | 1 | 2024 | 1885 | 0.120 |
Why?
|
Antigens, CD1 | 1 | 2018 | 439 | 0.120 |
Why?
|
Primary Graft Dysfunction | 1 | 2016 | 112 | 0.120 |
Why?
|
Cryopreservation | 2 | 2017 | 728 | 0.120 |
Why?
|
House Calls | 1 | 2017 | 161 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2018 | 7400 | 0.120 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4251 | 0.120 |
Why?
|
Organ Culture Techniques | 1 | 2017 | 792 | 0.120 |
Why?
|
Toll-Like Receptor 8 | 1 | 2015 | 90 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2017 | 4574 | 0.120 |
Why?
|
Risk Factors | 13 | 2024 | 74241 | 0.120 |
Why?
|
Mice, Knockout | 7 | 2013 | 14392 | 0.120 |
Why?
|
Risk Assessment | 5 | 2019 | 24022 | 0.120 |
Why?
|
Receptors, Immunologic | 1 | 2021 | 1408 | 0.120 |
Why?
|
Receptors, Interleukin-2 | 2 | 2011 | 564 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1812 | 0.120 |
Why?
|
Ribavirin | 1 | 2016 | 394 | 0.120 |
Why?
|
Kidney Function Tests | 3 | 2024 | 680 | 0.120 |
Why?
|
Waiting Lists | 1 | 2019 | 766 | 0.120 |
Why?
|
Gene Expression | 4 | 2021 | 7571 | 0.110 |
Why?
|
Nephritis | 1 | 2015 | 147 | 0.110 |
Why?
|
Fluorocarbons | 1 | 2019 | 492 | 0.110 |
Why?
|
Toll-Like Receptor 7 | 1 | 2015 | 165 | 0.110 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 385 | 0.110 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2017 | 544 | 0.110 |
Why?
|
Graft vs Host Reaction | 1 | 2014 | 99 | 0.110 |
Why?
|
Ultrasonography, Interventional | 2 | 2019 | 1496 | 0.110 |
Why?
|
Organ Preservation | 1 | 2017 | 382 | 0.110 |
Why?
|
Immunity, Cellular | 4 | 2014 | 1553 | 0.110 |
Why?
|
Receptors, Purinergic | 1 | 2014 | 66 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3726 | 0.110 |
Why?
|
Regenerative Medicine | 1 | 2017 | 307 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2016 | 575 | 0.110 |
Why?
|
Face | 1 | 2019 | 1025 | 0.110 |
Why?
|
DNA, Viral | 3 | 2017 | 2195 | 0.100 |
Why?
|
Exosomes | 1 | 2017 | 424 | 0.100 |
Why?
|
Viral Load | 2 | 2014 | 3328 | 0.100 |
Why?
|
Health Facilities | 1 | 2018 | 575 | 0.100 |
Why?
|
Skin | 3 | 2021 | 4473 | 0.100 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 292 | 0.100 |
Why?
|
Clinical Protocols | 1 | 2018 | 1436 | 0.100 |
Why?
|
Janus Kinases | 1 | 2013 | 249 | 0.100 |
Why?
|
Cytokines | 12 | 2021 | 7386 | 0.100 |
Why?
|
Glycolysis | 1 | 2016 | 836 | 0.100 |
Why?
|
Autoimmunity | 2 | 2019 | 1356 | 0.100 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 2007 | 509 | 0.100 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 379 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15308 | 0.100 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
Inflammation | 3 | 2024 | 10759 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2549 | 0.100 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 4 | 2000 | 826 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 803 | 0.100 |
Why?
|
Kidney Glomerulus | 1 | 2014 | 567 | 0.100 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39127 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2017 | 647 | 0.090 |
Why?
|
Calcium Compounds | 1 | 2011 | 38 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2018 | 2425 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 694 | 0.090 |
Why?
|
Boston | 3 | 2014 | 9327 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2455 | 0.090 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2013 | 254 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 2 | 2020 | 1645 | 0.090 |
Why?
|
Cells, Cultured | 9 | 2017 | 18927 | 0.090 |
Why?
|
Self Tolerance | 1 | 2011 | 123 | 0.090 |
Why?
|
Endothelium, Vascular | 2 | 2014 | 4420 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2013 | 4340 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2864 | 0.090 |
Why?
|
Macrophage Activation | 1 | 2013 | 552 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2008 | 11855 | 0.090 |
Why?
|
Glycoproteins | 1 | 2018 | 2203 | 0.090 |
Why?
|
Ureteral Neoplasms | 1 | 2011 | 107 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18222 | 0.090 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 494 | 0.090 |
Why?
|
Growth Inhibitors | 1 | 2011 | 374 | 0.090 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2011 | 1783 | 0.090 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1751 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3331 | 0.090 |
Why?
|
Peptides | 3 | 2011 | 4353 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9417 | 0.080 |
Why?
|
Killer Cells, Natural | 1 | 2019 | 2194 | 0.080 |
Why?
|
Acetates | 1 | 2011 | 319 | 0.080 |
Why?
|
Prevalence | 4 | 2008 | 15721 | 0.080 |
Why?
|
Imidazoles | 1 | 2015 | 1172 | 0.080 |
Why?
|
Nephrology | 2 | 2017 | 263 | 0.080 |
Why?
|
Tacrolimus | 3 | 2011 | 736 | 0.080 |
Why?
|
Protein Kinase C | 1 | 2013 | 1202 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2164 | 0.080 |
Why?
|
Cell Movement | 2 | 2018 | 5195 | 0.080 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4744 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3245 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2019 | 3044 | 0.080 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5366 | 0.080 |
Why?
|
Flow Cytometry | 4 | 2012 | 5871 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4021 | 0.080 |
Why?
|
Rats, Inbred BN | 8 | 1999 | 231 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1923 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2016 | 10423 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 609 | 0.070 |
Why?
|
Endomyocardial Fibrosis | 1 | 2007 | 41 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2017 | 991 | 0.070 |
Why?
|
Interleukin-23 | 1 | 2009 | 201 | 0.070 |
Why?
|
Metabolomics | 1 | 2017 | 1658 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3688 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1910 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 4 | 2016 | 2468 | 0.070 |
Why?
|
Cholesterol | 1 | 2016 | 2902 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2009 | 1848 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2017 | 2317 | 0.070 |
Why?
|
Polysaccharides, Bacterial | 2 | 1999 | 577 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2688 | 0.070 |
Why?
|
Apoptosis | 5 | 2017 | 9478 | 0.070 |
Why?
|
Simian virus 40 | 1 | 2007 | 291 | 0.070 |
Why?
|
Immunization | 3 | 2003 | 1218 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6486 | 0.070 |
Why?
|
Foot | 1 | 2010 | 575 | 0.070 |
Why?
|
Down-Regulation | 2 | 2011 | 2916 | 0.070 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2007 | 257 | 0.070 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1932 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2014 | 873 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1249 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2001 | 1348 | 0.060 |
Why?
|
Polyomavirus | 1 | 2006 | 234 | 0.060 |
Why?
|
Chimera | 2 | 2004 | 453 | 0.060 |
Why?
|
Obesity | 2 | 2017 | 12940 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2217 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2011 | 3417 | 0.060 |
Why?
|
Urine | 1 | 2006 | 362 | 0.060 |
Why?
|
Health Personnel | 1 | 2018 | 3337 | 0.060 |
Why?
|
Hand | 1 | 2010 | 902 | 0.060 |
Why?
|
Immunophenotyping | 3 | 2017 | 1867 | 0.060 |
Why?
|
Antigen-Presenting Cells | 3 | 2011 | 965 | 0.060 |
Why?
|
Lymphocytes | 5 | 2004 | 2603 | 0.060 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2011 | 782 | 0.060 |
Why?
|
Drug Antagonism | 1 | 2004 | 51 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5809 | 0.060 |
Why?
|
Phosphotyrosine | 1 | 2005 | 455 | 0.060 |
Why?
|
Hyperhomocysteinemia | 1 | 2004 | 118 | 0.060 |
Why?
|
Mesoderm | 1 | 2007 | 673 | 0.060 |
Why?
|
Disease Progression | 6 | 2017 | 13511 | 0.060 |
Why?
|
Models, Animal | 1 | 2010 | 2114 | 0.060 |
Why?
|
Mycoses | 1 | 2007 | 386 | 0.060 |
Why?
|
Linear Models | 1 | 2014 | 5869 | 0.060 |
Why?
|
Cell Line | 5 | 2011 | 15545 | 0.060 |
Why?
|
Heart Failure | 2 | 2019 | 11701 | 0.050 |
Why?
|
Rats, Inbred Strains | 3 | 2000 | 2087 | 0.050 |
Why?
|
Sclerosis | 1 | 2023 | 210 | 0.050 |
Why?
|
Heart | 1 | 2016 | 4431 | 0.050 |
Why?
|
Cohort Studies | 7 | 2021 | 41496 | 0.050 |
Why?
|
Nutrition Surveys | 1 | 2010 | 1723 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8246 | 0.050 |
Why?
|
Administration, Oral | 1 | 2011 | 4015 | 0.050 |
Why?
|
Aorta | 1 | 2010 | 2040 | 0.050 |
Why?
|
Chemokine CCL2 | 2 | 2012 | 602 | 0.050 |
Why?
|
United States | 7 | 2021 | 72341 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2021 | 781 | 0.050 |
Why?
|
Heart Diseases | 1 | 2015 | 2795 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3534 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8519 | 0.050 |
Why?
|
Antifungal Agents | 1 | 2007 | 752 | 0.050 |
Why?
|
Immunohistochemistry | 5 | 2021 | 11067 | 0.050 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2001 | 58 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12728 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2011 | 11512 | 0.050 |
Why?
|
Incidence | 4 | 2015 | 21366 | 0.050 |
Why?
|
Ribonucleases | 1 | 2002 | 264 | 0.050 |
Why?
|
Homocysteine | 1 | 2004 | 637 | 0.050 |
Why?
|
Surgery, Plastic | 1 | 2008 | 640 | 0.050 |
Why?
|
DNA Helicases | 1 | 2007 | 850 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2871 | 0.050 |
Why?
|
Postoperative Period | 1 | 2006 | 1818 | 0.050 |
Why?
|
Crosses, Genetic | 1 | 2002 | 752 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12052 | 0.050 |
Why?
|
Interleukins | 2 | 2013 | 782 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3610 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2003 | 897 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2016 | 16954 | 0.040 |
Why?
|
Bone Marrow | 1 | 2011 | 2911 | 0.040 |
Why?
|
Bone Marrow Transplantation | 2 | 1999 | 2692 | 0.040 |
Why?
|
Adoptive Transfer | 4 | 2011 | 823 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 585 | 0.040 |
Why?
|
Bacterial Vaccines | 2 | 1999 | 399 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 59222 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5301 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2002 | 1059 | 0.040 |
Why?
|
Protein Binding | 3 | 2011 | 9297 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 1 | 2001 | 270 | 0.040 |
Why?
|
DNA Replication | 1 | 2007 | 1415 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2003 | 767 | 0.040 |
Why?
|
MAP Kinase Signaling System | 2 | 2016 | 1480 | 0.040 |
Why?
|
Erythropoietin | 1 | 2004 | 719 | 0.040 |
Why?
|
Porins | 1 | 1999 | 78 | 0.040 |
Why?
|
Macrophages | 2 | 2013 | 5755 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4567 | 0.040 |
Why?
|
Neisseria meningitidis | 1 | 1999 | 108 | 0.040 |
Why?
|
bcl-X Protein | 2 | 2016 | 410 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2277 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5333 | 0.040 |
Why?
|
Recurrence | 2 | 2023 | 8457 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2011 | 2223 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 1130 | 0.040 |
Why?
|
Cross Reactions | 1 | 2000 | 819 | 0.040 |
Why?
|
Cricetinae | 1 | 2002 | 2412 | 0.040 |
Why?
|
Blotting, Western | 2 | 2016 | 5032 | 0.040 |
Why?
|
Clonal Deletion | 1 | 1998 | 74 | 0.040 |
Why?
|
Radiation Chimera | 1 | 1998 | 216 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2007 | 3702 | 0.040 |
Why?
|
Peptide Fragments | 3 | 1999 | 5103 | 0.040 |
Why?
|
Age Factors | 3 | 2011 | 18384 | 0.040 |
Why?
|
Vaccines, Conjugate | 1 | 1999 | 328 | 0.040 |
Why?
|
Vimentin | 1 | 2019 | 255 | 0.040 |
Why?
|
Uridine Monophosphate | 1 | 2018 | 66 | 0.040 |
Why?
|
Streptococcus agalactiae | 1 | 1999 | 337 | 0.040 |
Why?
|
Lymphocyte Transfusion | 1 | 1999 | 232 | 0.040 |
Why?
|
Oxides | 1 | 2019 | 401 | 0.040 |
Why?
|
Ligands | 3 | 2011 | 3264 | 0.040 |
Why?
|
Proteinuria | 2 | 1997 | 605 | 0.040 |
Why?
|
Endothelins | 1 | 1997 | 127 | 0.040 |
Why?
|
Ferric Compounds | 1 | 2019 | 378 | 0.040 |
Why?
|
Mice, Transgenic | 5 | 2011 | 9520 | 0.040 |
Why?
|
Podocytes | 1 | 2021 | 398 | 0.040 |
Why?
|
Genotype | 1 | 2012 | 12985 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2007 | 1796 | 0.040 |
Why?
|
Islets of Langerhans Transplantation | 2 | 1999 | 743 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2004 | 1504 | 0.040 |
Why?
|
Myosins | 1 | 2019 | 404 | 0.040 |
Why?
|
Fluorenes | 1 | 2018 | 157 | 0.040 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 1997 | 91 | 0.040 |
Why?
|
Immunodominant Epitopes | 1 | 1998 | 237 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12474 | 0.040 |
Why?
|
Chemokine CCL5 | 1 | 1997 | 214 | 0.030 |
Why?
|
Abscess | 1 | 2000 | 605 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 14025 | 0.030 |
Why?
|
Postoperative Care | 1 | 2003 | 1468 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 1999 | 602 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2015 | 22174 | 0.030 |
Why?
|
Tissue Preservation | 1 | 2017 | 174 | 0.030 |
Why?
|
HT29 Cells | 1 | 2016 | 192 | 0.030 |
Why?
|
DNA Primers | 2 | 2017 | 2814 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 783 | 0.030 |
Why?
|
Thailand | 1 | 2017 | 287 | 0.030 |
Why?
|
Models, Biological | 2 | 2006 | 9458 | 0.030 |
Why?
|
Serpins | 1 | 2017 | 247 | 0.030 |
Why?
|
Immunoglobulin G | 6 | 2011 | 4537 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2426 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 2007 | 1963 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2016 | 193 | 0.030 |
Why?
|
Mutation | 3 | 2018 | 30004 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 405 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6067 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 822 | 0.030 |
Why?
|
Immunization, Passive | 1 | 1998 | 617 | 0.030 |
Why?
|
Chemokines | 1 | 1999 | 956 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 730 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2007 | 3821 | 0.030 |
Why?
|
Research Report | 1 | 2018 | 367 | 0.030 |
Why?
|
Pain | 1 | 2010 | 5072 | 0.030 |
Why?
|
Brain Death | 1 | 1998 | 357 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1878 | 0.030 |
Why?
|
Growth Substances | 1 | 1997 | 759 | 0.030 |
Why?
|
Toll-Like Receptor 2 | 1 | 2016 | 344 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3552 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1624 | 0.030 |
Why?
|
Rabbits | 2 | 2011 | 4750 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 1999 | 988 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2012 | 1154 | 0.030 |
Why?
|
Autoimmune Diseases | 2 | 2011 | 2244 | 0.030 |
Why?
|
Oligopeptides | 1 | 1999 | 1179 | 0.030 |
Why?
|
Cold Temperature | 1 | 1997 | 783 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1997 | 1128 | 0.030 |
Why?
|
Pancreatitis, Chronic | 1 | 2016 | 280 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2015 | 302 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 2007 | 359 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 1999 | 1464 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1997 | 752 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1404 | 0.030 |
Why?
|
Pravastatin | 1 | 2015 | 392 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10516 | 0.030 |
Why?
|
Hematopoiesis | 2 | 1999 | 2049 | 0.030 |
Why?
|
Biological Transport, Active | 1 | 2013 | 323 | 0.030 |
Why?
|
Body Mass Index | 1 | 2011 | 12952 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 577 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 982 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2012 | 26072 | 0.030 |
Why?
|
Motion | 1 | 2016 | 779 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2813 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1998 | 976 | 0.030 |
Why?
|
Niacin | 1 | 2013 | 117 | 0.030 |
Why?
|
Nephrectomy | 1 | 1997 | 938 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2017 | 875 | 0.020 |
Why?
|
Yugoslavia | 1 | 2011 | 23 | 0.020 |
Why?
|
Neuroleptic Malignant Syndrome | 1 | 1992 | 74 | 0.020 |
Why?
|
Pilot Projects | 2 | 2017 | 8642 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3803 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2010 | 0.020 |
Why?
|
Medicare | 2 | 2021 | 6774 | 0.020 |
Why?
|
Microscopy | 1 | 2016 | 904 | 0.020 |
Why?
|
Video Recording | 1 | 2016 | 965 | 0.020 |
Why?
|
Hepacivirus | 1 | 2018 | 1330 | 0.020 |
Why?
|
Stem Cells | 1 | 2004 | 3517 | 0.020 |
Why?
|
Cystoscopy | 1 | 2011 | 131 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2020 | 5666 | 0.020 |
Why?
|
Iron | 1 | 2019 | 1791 | 0.020 |
Why?
|
Reoperation | 1 | 2021 | 4303 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 370 | 0.020 |
Why?
|
Turkey | 1 | 2011 | 254 | 0.020 |
Why?
|
Cell Division | 3 | 2004 | 4451 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1186 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 598 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 643 | 0.020 |
Why?
|
Base Sequence | 2 | 2017 | 12404 | 0.020 |
Why?
|
Immunoglobulin M | 3 | 1999 | 1527 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7804 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2007 | 5426 | 0.020 |
Why?
|
Up-Regulation | 2 | 2011 | 4111 | 0.020 |
Why?
|
Antibody Formation | 3 | 1999 | 1391 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2014 | 20118 | 0.020 |
Why?
|
Germany | 1 | 2011 | 872 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 890 | 0.020 |
Why?
|
Spleen | 3 | 1999 | 2290 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2636 | 0.020 |
Why?
|
Cell Polarity | 1 | 2011 | 638 | 0.020 |
Why?
|
Forecasting | 1 | 2017 | 2928 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1703 | 0.020 |
Why?
|
Artifacts | 1 | 2016 | 1912 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6586 | 0.020 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2007 | 110 | 0.020 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2007 | 151 | 0.020 |
Why?
|
Coronary Disease | 1 | 2001 | 5921 | 0.020 |
Why?
|
Ofloxacin | 1 | 2007 | 66 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2011 | 1822 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9616 | 0.020 |
Why?
|
Immunotherapy | 1 | 2002 | 4642 | 0.020 |
Why?
|
Rural Population | 1 | 2017 | 2277 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3584 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5311 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6304 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2507 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2621 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3149 | 0.020 |
Why?
|
Naphthyridines | 1 | 2007 | 143 | 0.020 |
Why?
|
Patient Care Team | 1 | 2017 | 2515 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2199 | 0.020 |
Why?
|
Survival Analysis | 2 | 2011 | 10088 | 0.020 |
Why?
|
Safety | 1 | 2010 | 1151 | 0.020 |
Why?
|
Cytosine | 1 | 2006 | 212 | 0.020 |
Why?
|
Ciprofloxacin | 1 | 2007 | 312 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2475 | 0.010 |
Why?
|
Neurons | 1 | 2004 | 9429 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3418 | 0.010 |
Why?
|
Isoxazoles | 1 | 2006 | 233 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2016 | 4507 | 0.010 |
Why?
|
Child | 2 | 2023 | 80154 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2813 | 0.010 |
Why?
|
Length of Stay | 2 | 2011 | 6417 | 0.010 |
Why?
|
Proteomics | 1 | 2017 | 3840 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 630 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1613 | 0.010 |
Why?
|
Rats, Nude | 1 | 2003 | 106 | 0.010 |
Why?
|
Receptors, OX40 | 1 | 2003 | 46 | 0.010 |
Why?
|
Tumor Necrosis Factors | 1 | 2003 | 109 | 0.010 |
Why?
|
Phenotype | 2 | 2017 | 16575 | 0.010 |
Why?
|
Quinolones | 1 | 2006 | 378 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36415 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2003 | 413 | 0.010 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2007 | 840 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 2003 | 312 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2011 | 2159 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2001 | 206 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2001 | 237 | 0.010 |
Why?
|
Exercise | 1 | 2017 | 5874 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2007 | 1361 | 0.010 |
Why?
|
Central Nervous System | 2 | 2000 | 1333 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2002 | 606 | 0.010 |
Why?
|
Carotid Artery Injuries | 1 | 2001 | 96 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2001 | 613 | 0.010 |
Why?
|
Anti-Glomerular Basement Membrane Disease | 1 | 2000 | 41 | 0.010 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2000 | 110 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2007 | 2410 | 0.010 |
Why?
|
Diet | 1 | 2017 | 8048 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8002 | 0.010 |
Why?
|
Myelin Proteins | 1 | 2000 | 212 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1999 | 130 | 0.010 |
Why?
|
Perforin | 1 | 1999 | 166 | 0.010 |
Why?
|
Cadaver | 1 | 2003 | 1358 | 0.010 |
Why?
|
Rats, Inbred ACI | 1 | 1998 | 34 | 0.010 |
Why?
|
Basement Membrane | 1 | 2000 | 348 | 0.010 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 1999 | 167 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15841 | 0.010 |
Why?
|
Virus Replication | 1 | 2007 | 2426 | 0.010 |
Why?
|
Drug Synergism | 1 | 2003 | 1756 | 0.010 |
Why?
|
Tunica Intima | 1 | 2001 | 458 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42225 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3390 | 0.010 |
Why?
|
Cell Separation | 1 | 2004 | 1721 | 0.010 |
Why?
|
Fasting | 1 | 2004 | 1603 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1999 | 914 | 0.010 |
Why?
|
Immunization Schedule | 1 | 1999 | 227 | 0.010 |
Why?
|
Thymectomy | 1 | 1999 | 195 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 1967 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1999 | 432 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2000 | 13402 | 0.010 |
Why?
|
Demyelinating Diseases | 1 | 2000 | 352 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13249 | 0.010 |
Why?
|
Fibrin | 1 | 2000 | 507 | 0.010 |
Why?
|
Heme Oxygenase-1 | 1 | 1999 | 366 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2002 | 1176 | 0.010 |
Why?
|
Neisseria gonorrhoeae | 1 | 1999 | 239 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14675 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6919 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11119 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1999 | 1762 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 282 | 0.010 |
Why?
|
Patient Selection | 1 | 2008 | 4246 | 0.010 |
Why?
|
Injections | 1 | 1998 | 832 | 0.010 |
Why?
|
Catheterization | 1 | 2001 | 1428 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1999 | 1056 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10756 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14610 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 800 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 1999 | 1022 | 0.010 |
Why?
|
Fibrosis | 1 | 2001 | 2052 | 0.010 |
Why?
|
Mice, Nude | 1 | 1999 | 3606 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2000 | 1791 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1999 | 1116 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4851 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9278 | 0.010 |
Why?
|
Trifluoperazine | 1 | 1992 | 37 | 0.010 |
Why?
|
RNA | 1 | 2001 | 2709 | 0.010 |
Why?
|
DNA | 1 | 2004 | 7189 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1992 | 684 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8164 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2001 | 3111 | 0.010 |
Why?
|
Cell Lineage | 1 | 1998 | 2549 | 0.010 |
Why?
|
Interleukin-2 | 1 | 1995 | 1891 | 0.000 |
Why?
|
Ischemia | 1 | 1997 | 1889 | 0.000 |
Why?
|
Piperidines | 1 | 1997 | 1656 | 0.000 |
Why?
|
Escherichia coli Infections | 1 | 1992 | 518 | 0.000 |
Why?
|
Myocardium | 1 | 2001 | 4746 | 0.000 |
Why?
|
Vaccination | 1 | 1999 | 3369 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 2000 | 17598 | 0.000 |
Why?
|
Urinary Tract Infections | 1 | 1992 | 801 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1999 | 7571 | 0.000 |
Why?
|
Blood Glucose | 1 | 1999 | 6392 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1992 | 1265 | 0.000 |
Why?
|
Sex Factors | 1 | 1997 | 10553 | 0.000 |
Why?
|
Depressive Disorder | 1 | 1992 | 3727 | 0.000 |
Why?
|
Brain | 1 | 2004 | 27094 | 0.000 |
Why?
|